We are live on
!
Find out more
CA
Corriente Advisors Portfolio holdings
AUM
$9.53M
1-Year Est. Return
805.26%
This Fund
S&P 500
This Quarter
Est. Return
+53.64%
1 Year Est. Return
+805.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$420M
AUM Growth
+$223M
(+113%)
Cap. Flow
+$160M
Cap. Flow
% of AUM
38.05%
Top 10 Holdings %
Top 10 Hldgs %
88.86%
Holding
27
New
11
Increased
7
Reduced
1
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Replimune Group
REPL
|
+$30.1M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$29.6M |
| 3 |
GoPro
GPRO
|
+$24.1M |
| 4 |
Cameco
CCJ
|
+$23.3M |
| 5 |
Cardiff Oncology
CRDF
|
+$19.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Beyond Meat
BYND
|
+$5.81M |
| 2 |
Virgin Galactic
SPCE
|
+$4.81M |
| 3 |
Village Farms International
VFF
|
+$4.32M |
| 4 |
Datadog
DDOG
|
+$4.09M |
| 5 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$4.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.65% |
| 2 | Technology | 33.36% |
| 3 | Energy | 7.6% |
| 4 | Industrials | 1.31% |
| 5 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAXR
1
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $96.5M | 22.97% |
2,500,000
+527,939
| +27% | +$15.5M |
|
|
RETA
2
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $64.9M | 15.45% |
525,000
+225,000
| +75% | +$29.6M |
|
|
3
Replimune Group
REPL
$859M
| $47.1M | 11.22% |
1,235,000
+722,500
| +141% | +$30.1M |
|
|
4
Cardiff Oncology
CRDF
$60.2M
| $36M | 8.56% |
2,000,000
+1,090,000
| +120% | +$19.2M |
|
|
5
Cameco
CCJ
$37.3B
| $29.2M | 6.94% |
+2,177,086
| New | +$23.3M |
|
|
6
GoPro
GPRO
$114M
| $27.7M | 6.6% |
+3,350,000
| New | +$24.1M |
|
7
Cue Biopharma
CUE
$131M
| $24M | 5.7% |
63,841
+15,926
| +33% | +$6.36M |
|
|
TFFP
8
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $19.3M | 4.6% |
54,000
+11,647
| +27% | +$4.48M |
|
|
MNDT
9
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $15.9M | 3.79% |
+690,000
| New | +$10.6M |
|
|
APTO
10
DELISTED
Aptose Biosciences, Inc.
APTO
| $12.7M | 3.02% |
6,444
-1,178
| -15% | -$2.77M |
|
|
CMPS
11
Compass Pathways
CMPS
$1.67B
| $9.05M | 2.15% |
+190,000
| New | +$8.1M |
|
12
Curis
CRIS
$9.02M
| $9.01M | 2.14% |
+2,750
| New | +$3.3M |
|
|
CNCE
13
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $8.6M | 2.05% |
+680,000
| New | +$7.75M |
|
14
DiaMedica Therapeutics
DMAC
$393M
| $8.18M | 1.95% |
806,900
+76,900
| +11% | +$421K |
|
15
Kratos Defense & Security Solutions
KTOS
$8.63B
| $5.49M | 1.31% |
+200,014
| New | +$4.38M |
|
16
NexGen Energy
NXE
$5.82B
| $2.76M | 0.66% |
+1,000,000
| New | +$2M |
|
|
ONCR
17
DELISTED
Oncorus, Inc.
ONCR
| $2.52M | 0.6% |
+78,043
| New | +$1.81M |
|
18
Ocular Therapeutix
OCUL
$1.96B
| $1.12M | 0.27% |
+53,934
| New | +$801K |
|
19
QuantumScape Corp
QS
$3.6B
| $84K | 0.02% |
+1,000
| New | +$36.6K |
|
|
20
Beyond Meat
BYND
$305M
| – | – |
-35,000
| Closed | -$5.81M |
|
|
21
Datadog
DDOG
$92.1B
| – | – |
-40,000
| Closed | -$4.09M |
|
22
Roku
ROKU
$21.4B
| – | – |
-20,000
| Closed | -$3.78M |
|
|
23
Virgin Galactic
SPCE
$329M
| – | – |
-12,500
| Closed | -$4.81M |
|
|
24
Village Farms International
VFF
$240M
| – | – |
-943,396
| Closed | -$4.32M |
|
|
CMRX
25
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-49,085
| Closed | -$122K |
|
Similar funds
SCM
FWM
TOPU
TGI
GIP
LCMP
SCM
TA
Corriente Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Corriente Advisors held 27 positions worth $420M, up 113% from $197M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Corriente Advisors deployed $160M of net new capital in Q4 2020, opening 11 new positions and adding to 7 existing holdings. Its largest new stake was GoPro: 3,350,000 shares worth $27.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 52% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Aptose Biosciences, Inc., an estimated $2.77M trimmed.
- Corriente Advisors's largest Q4 2020 buy was GoPro: 3,350,000 shares worth $27.7M.
- Corriente Advisors added most to Replimune Group in Q4 2020, an estimated $30.1M increase.
- Corriente Advisors's biggest Q4 2020 reduction was Aptose Biosciences, Inc., cutting an estimated $2.77M.
- Corriente Advisors fully exited Beyond Meat in Q4 2020, selling an estimated $5.81M.
- Corriente Advisors's ten largest holdings make up 89% of its $420M portfolio in Q4 2020.
- Corriente Advisors opened 11 new positions and closed 8 in Q4 2020.
- Corriente Advisors's portfolio value rose 113% quarter-over-quarter to $420M.
Based on Corriente Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.